Navigation Links
MacroGenics' Board of Directors Elects Paulo F. Costa as Chairman
Date:9/19/2013

aulo as the new Chair of our Board of Directors.  His proven skills in operations and commercialization are vital assets to MacroGenics."

Dr. David Stump was most recently Executive Vice President, Research and Development at Human Genome Sciences, Inc., (HGS) and joined the company in 1999. Prior to joining HGS, he held roles of increasing responsibility at Genentech, Inc., from 1989 to 1999, most recently as Vice President, Clinical Research and Genentech Fellow. Prior to joining Genentech, Dr. Stump was an Associate Professor of Medicine and Biochemistry at the University of Vermont. He earned an A.B. from Earlham College and an M.D. at Indiana University, followed by residency and fellowship training in internal medicine, hematology, oncology and biochemistry at the University of Iowa. He is currently a member of the Board of Directors of Sunesis Pharmaceuticals, Inc. and Dendreon Corp. as well as of the Board of Trustees of Earlham College.

"We welcome David to the Board of Directors of MacroGenics. His extensive leadership experience in clinical research and R&D and strong track record in the healthcare industry, make him an essential addition to the Board," said Scott Koenig.

Dr. Stump is replacing Board member Michael Steinmetz, Ph.D., Managing Director of Clarus Ventures, LLC.

"We want to thank Michael for his dedicated service and his contributions to MacroGenics' Board of Directors," added Scott Koenig. "It has been a real pleasure working with Michael over the last 13 years."

About MacroGenics, Inc.

MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. The company generates its pipeline of product candidates from its proprietary suite of next-ge
'/>"/>

SOURCE MacroGenics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ImaginAb and MacroGenics Collaborate to Develop In Vivo Imaging Agents for Autoimmune Diseases, Cancer
2. MacroGenics Appoints Jon Wigginton, M.D., as Senior Vice President, Clinical Development
3. MacroGenics to Receive $10 Million Milestone Payment from Servier for Dosing the First Patient in a Phase 1 Dose Expansion Trial of MGA271
4. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
5. Angeion Selects Hendrik Struik for Board of Directors
6. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
7. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
8. Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering
9. Young Innovations, Inc. Board Of Directors Declares Quarterly Dividend
10. Allscripts Adds Two Independent Directors to Board
11. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Belgium , Sept. 1, 2015 VolitionRx ... on developing blood-based diagnostic tests for a broad range of ... Executive Officer, Cameron Reynolds , is scheduled to attend ... is being held September 9-10, 2015 in Boston, ... on September 10. Wells Fargo Securities Research ...
(Date:9/1/2015)... , Sept. 1, 2015 Sargas ... Management (CCM) and Drug Adherence m Health applications ... automate the process of non face-to-face monitoring of ... this new release of our apps, doctors are ... services along with our ONCHIT certified Physician, Pharmacy ...
(Date:9/1/2015)... Sept. 1, 2015   Ivenix Inc. , ... management system, closed on a $42M round of ... Ventures. Cardinal Partners, CICA, Inc., Easterly Capital, Fidelity ... the round. This financing will support the company,s ... Leerink Partners LLC acted as the exclusive placement ...
Breaking Medicine Technology:VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 2VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 3VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 4SPAC International's Drug Adherence and Chronic Care Management App Now available at Apple App and Google Play stores 2Ivenix Inc. Secures $42 Million in Funding 2Ivenix Inc. Secures $42 Million in Funding 3
... telangiectasia-like disease and Nijmegen breakage syndrome offer ... and cancer vulnerability in people carrying the ... Scientists at St. Jude Children,s Research Hospital ... two related neurological diseases--ataxia telangiectasia-like disease (ATLD) ...
... MannKind Corporation (Nasdaq: MNKD ) ... equivalence of its commercial inhaler to the version of ... deliver AFRESA(TM), MannKind,s ultra rapid acting insulin that recently ... Bioequivalence of Clinical and Commercial Scale Inhalers Study 138 ...
Cached Medicine Technology:Study Shows How Defective DNA Repair Triggers Two Neurological Diseases 2Study Shows How Defective DNA Repair Triggers Two Neurological Diseases 3MannKind Reports Successful Completion of Device Bioequivalence Trial 2MannKind Reports Successful Completion of Device Bioequivalence Trial 3
(Date:9/1/2015)... ... September 01, 2015 , ... ... top-five hospital by U.S. News & World Report, to provide breaking news and ... Editorial and marketing groups within OncLive, which provides oncologists resources and information?they need ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... (NAPBS®) has announced that Edge Information Management has been granted continued ... Screening Credentialing Council (BSCC). , “Achieving and maintaining this accreditation takes ...
(Date:9/1/2015)... ... 2015 , ... The Jerry Segal Classic to benefit the patients of Magee ... Club in Lafayette Hill, PA. Over the past 26 years, the Classic, organized by ... services designed to support patients and their families during their time at Magee Rehabilitation ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... and analysis of pet vital signs and activity, today announced its integration with ... the most popular and widely-adopted veterinary hospital Practice Management Software packages in the ...
(Date:9/1/2015)... ... , ... With former IBMers among its founding members, Inmar has known the ... 35 years ago. A pilot program begun by the company in 2014 has proved ... intent on pursuing careers in these fields. The program is now open to area ...
Breaking Medicine News(10 mins):Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 2Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 3Health News:Edge Information Management Granted Continued NAPBS Accreditation 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 3Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 3Health News:Petpace-Cornerstone Integration Lowers Overhead, Raises Data Visibility for Veterinary Practices 2Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2
... a boost from a surprising source: the 2009 H1N1 pandemic ... strain developed antibodies that are protective against a variety of ... the University of Chicago have found. The results were published ... "Our data shows that infection with the 2009 pandemic ...
... , , Reproductive medicine is one of ... there are announcements of medical ,firsts, new rulings by ... heated debate among practitioners in the field, ethicists, legislators, ... is the forum where more than 9,000 of the ...
... News) -- Race and ethnicity play major roles in whether ... with minorities much less likely to undergo colonoscopies than white ... play: where people live. Research by oncologist Dr. ... Davis Cancer Center found that location makes a big difference ...
... January 10, 2011 -- While most blood tests require shipping a ... days for the results, a new device invented by a team ... just a pinprick of blood in a portable device that provides ... big step in point-of-care diagnostics, where testing can be performed in ...
... News) -- The first study to focus solely on the ... Sept. 11, 2001 attacks on the World Trade Center finds ... of the 3,271 evacuees of the Twin Towers surveyed in ... at least one current post-traumatic stress symptom, while 15 percent ...
... be most useful for clinical decision-making in trials in which ... recent study published online January 7 in The ... has been increasing interest in the value of patient-reported symptom ... secondary endpoints in new trials. Both the World Health Organization ...
Cached Medicine News:Health News:Pandemic flu strain could point way to universal vaccine 2Health News:Pandemic flu strain could point way to universal vaccine 3Health News:ESHRE bridges East and West for its 2012 Congress in Istanbul 2Health News:Geography May Influence Colon Cancer Screening Rates 2Health News:Engineering team invents lab-on-a-chip for fast, inexpensive blood tests 2Health News:Many Survivors of World Trade Center Attacks Suffered PTSD: Study 2Health News:Quality of life measures in breast cancer clinical trials 2
... Chamber Lenses: The Bausch & Lomb PMMA Posterior ... for primary implantation for the visual correction of ... older where a cataractous lens has been removed ... to be placed in the ciliary sulcus or ...
... are manufactured using the highest ... CQ UV PMMA material is ... single piece lenses. Unioptic lens ... nonphaco and phaco styles. All ...
... STAARVISC II is a sterile nonpyrogenic, ... hyaluronate. STAARVISC II contains 12 mg/ml of ... daltons) sodium hyaluronate dissolved in physiological saline. ... the viscosity is 105,000 cps (105 Pa ...
... viscoelastic agent for the surgeon who performs ... Amvisc possesses sufficient viscosity for excellent chamber ... cohesive so that complete removal at the ... quickly accomplished. Amvisc is priced to compete ...
Medicine Products: